Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sinecatechins Ointment, a Botanical Drug Derived From Green Tea, for the Treatment of Significant to Severe Secondary Provoked Vestibulodynia in Sexually Active, Post-Menopausal Women With Vulvovaginal Atrophy

NCT03682601 is registered in ClinicalTrials.gov with GTO Pharmaceutical, LLC as lead sponsor.

NCT NCT03682601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03682601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sinecatechins Ointment, a Botanical Drug Derived From Green Tea, for the Treatment of Significant to Severe Secondary Provoked Vestibulodynia in Sexually Active, Post-Menopausal Women With Vulvovaginal Atrophy
Lead sponsor
GTO Pharmaceutical, LLC
Phase
Phase 2
Overall status
Terminated
Start date
August 30, 2018
Completion date
February 13, 2021
Enrollment
32 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arousal disorders, sexual, dyspareunia, female sexual arousal disorder, female sexual dysfunction, genito-pelvic pain/penetration disorder, postmenopausal symptoms, sexual pain disorders, vestibulodynia, vulvodynia, vulvovaginal atrophy